Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipoprotein(a), or Lp(a), is a lipoprotein particle structurally similar to LDL, but with an additional protein, apolipoprotein(a) [apo(a)], covalently attached. Elevated Lp(a) levels are an independent genetic risk factor for cardiovascular diseases due to its roles in atherogenesis, thrombogenesis, and inflammation. It acts as a carrier for cholesterol and oxidized phospholipids. The precise physiological function of Lp(a) remains unclear.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipoprotein A (Lp(a)).